Biotech ETFs Poised for Surge: Guardant Health and Future Healthcare Equity ETF Lead the Way

Biotech ETFs are poised for a surge in 2025 due to falling interest rates and cheaper borrowing, as well as the power of computer-aided innovation. Guardant Health (GH) has returned 204% YTD and 50% in the last month alone. Biotech ETFs like the Future Health Care Equity ETF (GDOC) can harness these tailwinds and invest in innovators in areas like precision medicine and genomics. GDOC has returned 9.1% over the last month, beating its ETF Database Category average.